Furthermore, YTHDC2 was found to be decreased in NAFLD patients and the livers of lean mice, and suppressing YTHDC2 promoted triglyceride (TG) accumulation. This evidence concerns the gene YTHDC2 and metabolic dysfunction-associated steatotic liver disease.